It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Chronic obstructive pulmonary disease (COPD) kills over three million people worldwide every year. Despite its high global impact, the knowledge about the underlying molecular mechanisms is still limited. In this study, we aimed to extend the available knowledge by identifying a small set of COPD-associated genes. We analysed different publicly available gene expression datasets containing whole lung tissue (WLT) and airway epithelium (AE) samples from over 400 human subjects for differentially expressed genes (DEGs). We reduced the resulting sets of 436 and 663 DEGs using a novel computational approach that utilises a random depth-first search to identify genes which improve the distinction between COPD patients and controls along the first principle component of the data. Our method identified small sets of 10 and 15 genes in the WLT and AE, respectively. These sets of genes significantly (p < 10–20) distinguish COPD patients from controls with high fidelity. The final sets revealed novel genes like cysteine rich protein 1 (CRIP1) or secretoglobin family 3A member 2 (SCGB3A2) that may underlie fundamental molecular mechanisms of COPD in these tissues.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Norwegian University of Science and Technology (NTNU), Department of Chemical Engineering, Trondheim, Norway (GRID:grid.5947.f) (ISNI:0000 0001 1516 2393)
2 Universities of Giessen and Marburg Lung Centre, Philipps University Marburg, Institute for Lung Research, Marburg, Germany (GRID:grid.10253.35) (ISNI:0000 0004 1936 9756); Maastricht University Medical Center (MUMC+), Department of Medical Microbiology, Maastricht, The Netherlands (GRID:grid.412966.e) (ISNI:0000 0004 0480 1382)
3 Universities of Giessen and Marburg Lung Centre, Philipps University Marburg, Institute for Lung Research, Marburg, Germany (GRID:grid.10253.35) (ISNI:0000 0004 1936 9756); University Medical Center Marburg, Universities of Giessen and Marburg Lung Center, Philipps University Marburg, Department of Pulmonary and Critical Care Medicine, Hesse, Germany (GRID:grid.10253.35) (ISNI:0000 0004 1936 9756); Institute for Lung Health (ILH), Giessen, Germany (GRID:grid.10253.35); Member of the German Center for Lung Research (DZL), the German Center for Infection Research (DZIF), and the Center for Synthetic Microbiology (SYNMIKRO) Marburg, Hesse, Germany (GRID:grid.10253.35)